Best Platelet Aggregation Inhibitor for myocardial infarction
Top-rated pick: Eptifibatide — pharmaranks score 64/100, the highest of the 2 Platelet Aggregation Inhibitor drugs used for myocardial infarction, ranked by our independent FDA recall-safety score. Compare them with all treatments for myocardial infarction or the full Platelet Aggregation Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 2 platelet aggregation inhibitor drugs we rate for myocardial infarction, none are yet flagged as generics in our price data, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for myocardial infarction; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for myocardial infarction
Top platelet aggregation inhibitor for myocardial infarction: 1. Eptifibatide · 2. Aggrastat
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 64/100 | Prescription | Injectable | No data | — | View → | |
| 2 | Not yet rated | Prescription | Injectable | No data | — | View → |
Full ranking · 2 drugs
eptifibatide
PrescriptionFDA-sourced
Eptifibatide is a platelet aggregation inhibitor used to treat Unstable Angina, Coronary Disease, Myocardial Infarction.
Price varies
aggrastat
PrescriptionFDA-sourced
Aggrastat (Tirofiban Hydrochloride) is a platelet aggregation inhibitor used to treat Unstable Angina, Coronary Disease, Myocardial Infarction.
Price varies
Frequently asked
- What is the best platelet aggregation inhibitor for myocardial infarction?
- By our independent recall-safety rating — not an efficacy measure — eptifibatide ranks highest among Platelet Aggregation Inhibitor drugs used for myocardial infarction. Always consult a professional.
- Which platelet aggregation inhibitor drugs treat myocardial infarction?
- pharmaranks lists 2 Platelet Aggregation Inhibitor products used for myocardial infarction, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
Where this ranking comes from
Our score is computed from public FDA data — not from opinion, sponsorship or user votes. How we rate.
- FDA Drug Enforcement (recall) database — the recall history behind the safety score
- DailyMed (NIH National Library of Medicine) — the FDA labels we quote for uses, dosing and warnings
- Drugs@FDA — approvals, strengths and marketing status